Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myasthenia Gravis 4 Carcinoma, Hepatocellular 2 Skin Neoplasms 1 Nervous System Diseases 1 Melanoma 1 Hepatitis 1 Colitis 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1

Interventions

Mycophenolic Acid 2 Blood Specimen Collection 2 vedolizumab 1 bavituximab 1 Ursodeoxycholic Acid 1 Surveys and Questionnaires 1 Steroids 1 Spermine Synthase 1 Sorafenib 1 Sofosbuvir 1 Ribavirin 1 Prednisone 1 Photopheresis 1 Phlebotomy 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Methoxsalen 1 Liquid Biopsy 1 Infliximab 1 Clinical Protocols 1 Azathioprine 1 Adrenal Cortex Hormones 1 3-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hepatitis × Azathioprine × Clear all

NCT07619898 2026-06-02

PHOENIX-ECP

Therakos LLC

Phase 2 Not yet recruiting

Colitis, Hepatitis, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡